Volume 16 Supplement 2
3rd International Clinical Trials Methodology Conference
Meeting abstracts
Publication of this supplement was funded by the 3rd Clinical Trials Methodology Conference.
3rd International Clinical Trials Methodology Conference. Go to conference site.
Glasgow, UK16-17 November 2015
Page 2 of 7
-
Citation: Trials 2015 16(Suppl 2):O48
-
Improving efficiency of on-site monitoring in multicentre clinical trials by targeting visits
Citation: Trials 2015 16(Suppl 2):O49 -
The role of an in-house audit group as an innovative tool to review clinical trials
Citation: Trials 2015 16(Suppl 2):O50 -
Blindingly obvious (once revealed): a novel approach to blinding medicinal products for injection
Citation: Trials 2015 16(Suppl 2):O51 -
How was it for you? - obtaining feedback from staff at study sites for the HPS2-thrive trial
Citation: Trials 2015 16(Suppl 2):O52 -
Investigation of the shortcomings of the consort 2010 statement for the reporting of group sequential randomised controlled trials
Citation: Trials 2015 16(Suppl 2):O53 -
Methods for evaluating innovative surgery: a nested ideal phase 2 study within an external randomised pilot (the ROMIO trial)
Citation: Trials 2015 16(Suppl 2):O54 -
A systematic review of the use of an expertise-based randomised trial design
Citation: Trials 2015 16(Suppl 2):O55 -
A framework for the design and analysis of phase III randomised trials in uncommon diseases
Citation: Trials 2015 16(Suppl 2):O56 -
Design of the myechild trial, an international randomised phase III clinical trial in children with acute myeloid leukaemia incorporating an embedded dose finding study
Citation: Trials 2015 16(Suppl 2):O57 -
Comparison of a frequentist and Bayesian response-adaptive randomisation approach in multi-stage phase II selection trials with multiple experimental arms
Citation: Trials 2015 16(Suppl 2):O58 -
Introducing personalised risk based intervals in screening for diabetic retinopathy: development, implementation and assessment of safety, cost-effectiveness and patient experience (ISDR): a case study in the use of automated systems in trials
Citation: Trials 2015 16(Suppl 2):O59 -
Video adjudication in clinical trials: enabling distribution of expertise and accurate scoring
Citation: Trials 2015 16(Suppl 2):O60 -
Experience from creating electronic systems with generic endpoint review and adjudication flows
Citation: Trials 2015 16(Suppl 2):O61 -
Design, validity and clinical utility of smartphone app to assess short-term pain trajectories
Citation: Trials 2015 16(Suppl 2):O62 -
A better participant experience using sms for real time data collection
Citation: Trials 2015 16(Suppl 2):O63 -
Development and evaluation of an electronic diary for recording patient reported outcomes in the overt study
Citation: Trials 2015 16(Suppl 2):O64 -
Evaluating the use of real-time data collection using SMS texts in the SIMS study
Citation: Trials 2015 16(Suppl 2):O65 -
Data sharing in clinical trials - practical guidance on anonymising trial datasets
Citation: Trials 2015 16(Suppl 2):O66 -
Supporting clinical trials through healthcare informatics
Citation: Trials 2015 16(Suppl 2):O67 -
Challenges of linking to routine healthcare records in UK Biobank
Citation: Trials 2015 16(Suppl 2):O68 -
Are we getting the whole picture? Measuring outcomes using routinely collected data in long term follow-up: an example from BB:2-6
Citation: Trials 2015 16(Suppl 2):O69 -
Managing the morass. Lessons learned from establishing a data linkage model for long-term follow up of a trial cohort using routine health and education data
Citation: Trials 2015 16(Suppl 2):O70 -
Can we reduce bias in open-label trials when blinded outcome assessment is not possible? An example from the trigger trial
Citation: Trials 2015 16(Suppl 2):O71 -
Selective reporting in clinical trials - an examination of discrepancy rates in pre-specified and reported outcomes in articles submitted to the BMJ
Citation: Trials 2015 16(Suppl 2):O72 -
What is the effect of patient-reported outcome (PRO) item order on prioritisation of PROs in the development of a core outcome set?
Citation: Trials 2015 16(Suppl 2):O73 -
Using existing trial data to inform the development of core outcome sets and improve efficiencies in research
Citation: Trials 2015 16(Suppl 2):O74 -
Rapid recruitment of large cohort to support trials in general practice: the role of FARSITE
Citation: Trials 2015 16(Suppl 2):O75 -
Optimising participation and generalisability: the use of opt-out recruitment for an implementation trial in primary care
Citation: Trials 2015 16(Suppl 2):O76 -
Recruitment to clinical trials - the use of social media
Citation: Trials 2015 16(Suppl 2):O77 -
Randomized controlled trials: who fails run-in?
Citation: Trials 2015 16(Suppl 2):O78 -
Testosterone replacement in young male cancer survivors (TRYMS) - pragmatic adaptation of trial design for a trial struggling with recruitment
Citation: Trials 2015 16(Suppl 2):O79 -
Learning more from exploratory trials of complex interventions: exploiting the complexity of complex interventions to empirically optimise the content and delivery of intervention packages for evaluation in a confirmatory trial
Citation: Trials 2015 16(Suppl 2):O80 -
Do pragmatic trials trade-off internal validity for external validity?
Citation: Trials 2015 16(Suppl 2):O81 -
Designing, implementing and analysing a virtual trial
Citation: Trials 2015 16(Suppl 2):O82 -
Evaluating statistical characteristics of biomarker-guided trial designs
Citation: Trials 2015 16(Suppl 2):O83 -
Type I error control in biomarker-stratified clinical trials
Citation: Trials 2015 16(Suppl 2):O84 -
Combining multiple predictive markers in stratified medicine
Citation: Trials 2015 16(Suppl 2):O85 -
Prediction of treatment benefit in high-dimensional cox models via gene signatures in randomized clinical trials
Citation: Trials 2015 16(Suppl 2):O86 -
Defining feasibility and pilot studies in preparation for randomised controlled trials: using consensus methods and validation to develop a conceptual framework
Citation: Trials 2015 16(Suppl 2):O87 -
Maximising the impact of qualitative research in feasibility studies for randomised controlled trials: guidance for researchers
Citation: Trials 2015 16(Suppl 2):O88 -
Recruitment progression rules for internal pilot studies monitoring recruitment
Citation: Trials 2015 16(Suppl 2):O89 -
Statistical challenges in assessing potential efficacy of complex interventions in pilot or feasibility studies
Citation: Trials 2015 16(Suppl 2):O90 -
Assessing the impact of patient and public involvement on recruitment and retention in clinical trials: a systematic review
Citation: Trials 2015 16(Suppl 2):O91 -
Developing a toolkit for patient and public involvement in a clinical trials unit
Citation: Trials 2015 16(Suppl 2):O92 -
Realising the potential of patient and public involvement to make a difference: what can trial teams do?
Citation: Trials 2015 16(Suppl 2):O93 -
Novel patient engagement and recruitment strategies for an RCY of two NHS treatments for ankle osteoarthritis - total ankle replacement versus arthrodesis - the TARVA trial
Citation: Trials 2015 16(Suppl 2):O94 -
Improving health in children with disabilities: an intervention-development study to support participation in leisure in 8-12 year olds with communication and mobility limitations
Citation: Trials 2015 16(Suppl 2):P1 -
Using results from a UK-wide survey to justify choice of comparator for the treatment of severe chronic hand eczema
Citation: Trials 2015 16(Suppl 2):P2 -
What can we learn from experience? Impact of healthcare provider effects in the total or partial knee arthroplasty trial (TOPKAT)
Citation: Trials 2015 16(Suppl 2):P3
Follow
Annual Journal Metrics
-
2022 Citation Impact
2.5 - 2-year Impact Factor
2.5 - 5-year Impact Factor
0.827 - SNIP (Source Normalized Impact per Paper)
0.814 - SJR (SCImago Journal Rank)2023 Speed
33 days submission to first editorial decision for all manuscripts (Median)
129 days submission to accept (Median)2023 Usage
6,282,238 downloads
5,569 Altmetric mentions